1. Kohler, G. and Milstein, C. (1975) Continuous culture of fused cells secreting antibody of predefined specificity.Nature 256, 495–497.
2. Gullick, W. J. (1991) Prevalence of aberrant expression of the epidermal growth factor receptor in human cancers.Br. Med. Bull. 47(1), 87–98.
3. Masui, H. Kawamoto, T., Sato, J. D., Wolf, B., Sato, G., and Mendelsohn, J. (1984) Growth inhibition of human tumor cells in athymic mice by anti-epidermal growth factor receptor monoclonal antibodies.Cancer Res.44, 1002–1007.
4. Rodeck, U., Herlyn, M., Herlyn, D. Molthoff, C., Atkinson, B., Varello, M., Steplewski, Z., and Koprowski, H. (1987) Tumor growth modulation by a monoclonal antibody to the epidermal growth factor receptor: immunologically mediated and effector cell-independent effects.Cancer Res. 47, 3692–3696.
5. Abound-Pirak, E., Hurwitz, E., Pirak, M. E., Bellot, F., Schlessinger, J., and Sela, M. (1988) Efficacy of antibodies to epidermal growth factor receptor against KB carcinoma in vitro and in nude mice.J. Natl. Cancer Inst. 80, 1605–1611.